# Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes

> **NCT03875469** · NA · COMPLETED · sponsor: **Bayer** · enrollment: 425 (actual)

## Conditions studied

- Computed Tomography

## Interventions

- **DEVICE:** Centargo injector (BPI 1000045)
- **DEVICE:** Stellant MP injector

## Key facts

- **NCT ID:** NCT03875469
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-21
- **Primary completion:** 2020-03-10
- **Final completion:** 2020-03-10
- **Target enrollment:** 425 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03875469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03875469, "Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03875469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*